United States· US:68479-371_2b0d2813-6704-4782-93f6-a650999beba9
BIOLUMIN-C HEAT AGING PROTECTOR SPF50
A medicinal product containing octocrylene; homosalate; octisalate; avobenzone, registered in United States by Dermalogica, LLC..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- OCTOCRYLENE; HOMOSALATE; OCTISALATE; AVOBENZONE
- Manufacturer
- Dermalogica, LLC.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 8
- ndc1168479-371-01
- ndc1168479-371-02
- ndc1168479-371-04
- ndc1168479-371-05
- ndc1168479371011 BOTTLE in 1 CARTON (68479-371-01) / 15 mL in 1 BOTTLE
- ndc1168479371021 BOTTLE in 1 CARTON (68479-371-02) / 50 mL in 1 BOTTLE
- ndc116847937104150 mL in 1 BOTTLE (68479-371-04)
- ndc1168479371051 BOTTLE in 1 CARTON (68479-371-05) / 5 mL in 1 BOTTLE
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Octocrylene; homosalate; octisalate; avobenzone in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/78360701-367c-4edf-a826-87059fc37786 GET /v1/drugs/78360701-367c-4edf-a826-87059fc37786?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": "10; 7; 5; 3",
"substance": "OCTOCRYLENE; HOMOSALATE; OCTISALATE; AVOBENZONE",
"productndc": "68479-371",
"dosage_form": "LOTION",
"dea_schedule": null,
"strength_unit": "g/100mL; g/100mL; g/100mL; g/100mL",
"application_number": "M020",
"marketing_category": "OTC MONOGRAPH DRUG"
}See everything about octocrylene; homosalate; octisalate; avobenzone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.